A controversial ASCO presentation underscores risk Bristol, Nektar carry with experimental cancer drug

08:34 EDT 3 Jun 2018 | STAT

If anything, the presentation raised more doubts.

More From BioPortfolio on "A controversial ASCO presentation underscores risk Bristol, Nektar carry with experimental cancer drug"